Ballerup, Denmark

Malene Bertelsen

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Malene Bertelsen: Innovator in Antibody Research

Introduction

Malene Bertelsen is a notable inventor based in Ballerup, Denmark. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of three patents to her name, her work focuses on innovative solutions for treating various skin conditions.

Latest Patents

One of her latest patents involves Anti-IL-22R antibodies. This invention relates to antibodies and antigen binding fragments that specifically bind to the cytokine receptor IL-22R, particularly the human IL-22R. The patent also encompasses pharmaceutical compositions that include these antibodies or fragments, along with methods for treating psoriasis, psoriatic arthritis, and atopic dermatitis. This groundbreaking work has the potential to improve the quality of life for many patients suffering from these conditions.

Career Highlights

Throughout her career, Malene has worked with prominent companies in the biotechnology sector, including Argenx BV and Argenx BVBA. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in antibody research.

Collaborations

Some of her notable coworkers include Christophe Frederic Jerome Blanchetot and Birgitte Ursø, who have collaborated with her on various projects. Their combined expertise has further enhanced the impact of her inventions.

Conclusion

Malene Bertelsen's innovative work in antibody research exemplifies the importance of scientific advancements in medicine. Her contributions continue to pave the way for new treatments and improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…